ES2071143T3 - Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270. - Google Patents

Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.

Info

Publication number
ES2071143T3
ES2071143T3 ES91103055T ES91103055T ES2071143T3 ES 2071143 T3 ES2071143 T3 ES 2071143T3 ES 91103055 T ES91103055 T ES 91103055T ES 91103055 T ES91103055 T ES 91103055T ES 2071143 T3 ES2071143 T3 ES 2071143T3
Authority
ES
Spain
Prior art keywords
sub
antibiotic
factors
eyt
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91103055T
Other languages
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Ermenegildo Restelli
Pietro Ferrari
Maurizio Denaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2071143T3 publication Critical patent/ES2071143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA INVENCION SE DIRIGE A NUEVAS SUSTANCIAS ANTIBIOTICAS DENOMINADAS ANTIBIOTICO GE 2270 FACTORES B SUB 1, B SUB 2, C SUB 1, C SUB 2, D SUB 1, D SUB 2, E Y T, SUS SALES DE ADICION, SUS COMPOSICIONES FARMACEUTICAS Y SU USO COMO MEDICAMENTOS, ESPECIALMENTE EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS QUE CAUSADAS POR MICROORGANISMOS SUSCEPTIBLES A ELLOS.
ES91103055T 1990-03-08 1991-03-01 Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270. Expired - Lifetime ES2071143T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90104409 1990-03-08
EP90120214 1990-10-22

Publications (1)

Publication Number Publication Date
ES2071143T3 true ES2071143T3 (es) 1995-06-16

Family

ID=26125004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91103055T Expired - Lifetime ES2071143T3 (es) 1990-03-08 1991-03-01 Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.

Country Status (11)

Country Link
US (2) US5747295A (es)
EP (1) EP0451486B1 (es)
JP (1) JP3107584B2 (es)
KR (1) KR0165684B1 (es)
AT (1) ATE121459T1 (es)
CA (1) CA2037779C (es)
DE (1) DE69108972T2 (es)
DK (1) DK0451486T3 (es)
ES (1) ES2071143T3 (es)
GR (1) GR3015899T3 (es)
IE (1) IE67973B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0529410B1 (en) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Antibiotic GE 2270 factor C2a
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
AU3805295A (en) * 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
CA2212437A1 (en) * 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
ES2115424T3 (es) * 1995-02-07 1998-06-16 Biosearch Italia Spa Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
DE69718442T2 (de) * 1996-02-14 2003-04-30 Biosearch Italia S.P.A., Gerenzano Derivate des antibiotisch wirkenden faktors ge2270
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EA200900816A1 (ru) * 2006-12-20 2009-12-30 Новартис Аг Антибактериальные соединения и способы их получения
CA2688621A1 (en) * 2007-06-04 2008-12-11 Novartis Ag Macrocycles and their uses
NZ585788A (en) 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399247A1 (fr) * 1977-08-04 1979-03-02 Rhone Poulenc Ind Antibiotique 35665 rp, sa preparation et les compositions qui les contiennent
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) * 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (en) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Antibiotic GE 2270 factor C2a
DE69718442T2 (de) * 1996-02-14 2003-04-30 Biosearch Italia S.P.A., Gerenzano Derivate des antibiotisch wirkenden faktors ge2270

Also Published As

Publication number Publication date
EP0451486B1 (en) 1995-04-19
DE69108972T2 (de) 1995-10-19
GR3015899T3 (en) 1995-07-31
EP0451486A1 (en) 1991-10-16
KR910016938A (ko) 1991-11-05
CA2037779C (en) 2002-11-05
US5843890A (en) 1998-12-01
ATE121459T1 (de) 1995-05-15
DK0451486T3 (da) 1995-05-08
KR0165684B1 (ko) 1999-01-15
CA2037779A1 (en) 1991-09-09
IE67973B1 (en) 1996-05-15
JPH04217988A (ja) 1992-08-07
DE69108972D1 (de) 1995-05-24
US5747295A (en) 1998-05-05
IE910754A1 (en) 1991-09-11
JP3107584B2 (ja) 2000-11-13

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2151906T3 (es) Utilizacion de envolventes de bacterias del orden de las beggiatoales o del genero vitreoscilla como ingrediente activo de un medicamento destinado a estimular la inmunidad no especifica.
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
ES2054844T3 (es) Nuevos esteroides que comprenden un ciclo espiranico con 3, 4 o 6 eslabones en posicion 17, su procedimiento, y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
YU51095A (sh) Benzokazolil - i benzotiazolil-oksazo lidinoni
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
DE69019659D1 (de) Mehrfach teilbare Tablettenstruktur.
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
BRPI0112452B8 (pt) derivados de pleuromutilinas tendo atividade antibacteriana e composição farmacêutica contendo os mesmos
ES2040207T3 (es) Un procedimiento para preparar una sustancia antibiotica.
ES2066914T3 (es) Factores a1, a2, a3 y h del antibiotico ge 2270.
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ES2061218T3 (es) Composiciones farmaceuticas estabilizadas.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
NL185923C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede penam-3-carbonzuur-1,1-dioxyde-derivaat.
ES2127761T3 (es) Vacuna contra la dermatomicosis.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451486

Country of ref document: ES